Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

BrightPath Biotherapeutics

ブライトパス・バイオ

4594 · TSE · Pharmaceutical · 1 article

Financials Company only

Revenue¥84,000−92.6% year on yearCompany only · FY3/26

Ordinary profit−¥1.29bnCompany only · FY3/26

Performance over time

Revenue
¥15.4mFY3/22
¥5.28mFY3/23
¥72,000FY3/24
¥1.13mFY3/25
¥84,000FY3/26
Ordinary profit
−¥1.48bnFY3/22
−¥1.47bnFY3/23
−¥1.16bnFY3/24
−¥1.15bnFY3/25
−¥1.29bnFY3/26
Op. cash flow
−¥1.51bnFY3/22
−¥1.20bnFY3/23
−¥1.16bnFY3/24
−¥1.25bnFY3/25
−¥1.37bnFY3/26

People & pay

Employees23 peopleFY3/26

Average salary¥9.38mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearRevenueOrdinary profitEPSTotal assetsNet assetsOp. cash flow
FY3/26¥84,000−92.6% year on year−¥1.29bn−¥11.70¥2.60bn¥2,368m−¥1.37bn
FY3/25¥1,133,000+1473.6% year on year−¥1.15bn−¥14.12¥1.12bn¥925m−¥1.25bn
FY3/24¥72,000−98.6% year on year−¥1.16bn−¥18.21¥1.23bn¥979m−¥1.16bn
FY3/23¥5,280,000−65.7% year on year−¥1.47bn−¥24.90¥1.70bn¥1,568m−¥1.20bn
FY3/22¥15,408,000−¥1.48bn−¥28.55¥2.77bn¥2,531m−¥1.51bn

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YJ3C · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:4594

Tokyo Brief coverage

All articles loaded · 1 shown

5% holders

Latest disclosed holders and exits below 5%.

1 holder · data through

5% holders
HolderStakeChangePurposeFiling
PhillipCapital Japan Ltd.
Original (Japanese)フィリップ・キャピタル証券株式会社
18.34%−1.56 ppPure investmentPure investment
Original (Japanese)純投資
Filed  — filing S100ZEGA